Berkeley Lights, Inc. (BLI) announced that it has entered into a collaboration to explore multiple lines of inquiry aimed at advancing cellular therapies, including CAR-T therapeutics, with Megan Suhoski Davis, Director of the Product Development Laboratory (PDL) within the Center for Cellular Immunotherapies in the University of Pennsylvania'sPerelman School of Medicine (Penn Medicine). BLI's single cell analytics platforms and workflow automation capabilities combined with the cancer immunotherapy expertise of the group at the Center for Cellular Immunotherapies at Penn Medicine, will be used to explore new methods of creating, defining, and testing of CAR-T immunotherapies.